These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1686687)

  • 21. [DNA restriction fragment length polymorphism (RFLP) of insulin and apolipoprotein A-I (apo A-I) genes in patients with diabetes mellitus coexistent with polyendocrinopathy].
    Grzywa M; Buraczyńska M; Tatoń J; Matwiszyn B
    Pol Tyg Lek; 1987 Dec; 42(50):1598-601. PubMed ID: 2898774
    [No Abstract]   [Full Text] [Related]  

  • 22. [Genetic-epidemiological studies of apolipoprotein(a) polymorphism and its significance in nephrological diseases and type I diabetes mellitus].
    Kronenberg F; Auinger M; Dieplinger H
    Acta Med Austriaca; 1999; 26(5):142-7. PubMed ID: 11512190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The genetics of the hyperlipidemias and coronary artery disease.
    Berg K
    Prog Clin Biol Res; 1982; 103 Pt B():111-25. PubMed ID: 7163216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Connection of polymorphic alleles of the gene cluster AI/CIII/AIV with disturbed lipid metabolism].
    Safronov VV; Berlova AL; Metel'skaia VA
    Mol Biol (Mosk); 1994; 28(1):216-23. PubMed ID: 8145752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coronary artery disease, lipid disorders and genetic polymorphisms.
    Ordovas JM; Schaefer EJ
    Ann Biol Clin (Paris); 1988; 46(1):24-9. PubMed ID: 2898907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between the eNOS (Glu298Asp) and the RAS genes polymorphisms and premature coronary artery disease in a Turkish population.
    Berdeli A; Sekuri C; Sirri Cam F; Ercan E; Sagcan A; Tengiz I; Eser E; Akin M
    Clin Chim Acta; 2005 Jan; 351(1-2):87-94. PubMed ID: 15563875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Characteristics of apolipoprotein polymorphism in a Hungarian population].
    Császár A
    Orv Hetil; 1997 Sep; 138(36 Suppl 2):2296-7. PubMed ID: 9340574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Restriction fragment length polymorphisms in apolipoprotein genes in diabetes mellitus].
    Itoh H; Kajinami K; Mabuchi H; Takeda R
    Nihon Rinsho; 1991 Feb; 49 Suppl():542-7. PubMed ID: 1674555
    [No Abstract]   [Full Text] [Related]  

  • 29. Detection of polymorphisms in the 5'-flanking region of the gene for apolipoprotein(a).
    Ichinose A; Kuriyama M
    Biochem Biophys Res Commun; 1995 Apr; 209(1):372-8. PubMed ID: 7726859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Molecular biology of apolipoproteins in genesis of hyperlipidemias and atherosclerosis].
    Hata Y
    Nihon Rinsho; 1993 Jun; 51(6):1668-76. PubMed ID: 8320847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcriptional regulatory mechanisms of the human apolipoprotein genes in vitro and in vivo.
    Zannis VI; Kan HY; Kritis A; Zanni EE; Kardassis D
    Curr Opin Lipidol; 2001 Apr; 12(2):181-207. PubMed ID: 11264990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic determinants of atherosclerosis-related dyslipidemias and their clinical implications.
    Galton DJ
    Clin Chim Acta; 1997 Jan; 257(2):181-97. PubMed ID: 9118562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Epidemiology and molecular genetics of atherosclerosis].
    Cambien F
    Journ Annu Diabetol Hotel Dieu; 1991; ():19-24. PubMed ID: 1679467
    [No Abstract]   [Full Text] [Related]  

  • 34. Restriction fragment length polymorphism of the apoprotein A-I-C-III gene cluster in control and stroke-prone white and black subjects: racial differences.
    Graffagnino C; Alberts MJ
    Stroke; 1993 Jun; 24(6):909-10. PubMed ID: 8099455
    [No Abstract]   [Full Text] [Related]  

  • 35. Apolipoproteins and metabolism in atherosclerosis.
    Gotto AM
    Trans Am Clin Climatol Assoc; 1990; 101():46-57; discussion 57-8. PubMed ID: 2486446
    [No Abstract]   [Full Text] [Related]  

  • 36. Multiple RFLPs at the human apolipoprotein D (APOD) locus.
    Drayna D; Scott JD; Lawn R
    Nucleic Acids Res; 1987 Nov; 15(22):9617. PubMed ID: 2891117
    [No Abstract]   [Full Text] [Related]  

  • 37. Could apolipoprotein E polymorphisms be hidden behind the relation between bone mineral density and atherosclerosis in hemodialysis patients?
    Liberopoulos EN; Elisaf MS
    Osteoporos Int; 2003 Nov; 14(11):957. PubMed ID: 14593455
    [No Abstract]   [Full Text] [Related]  

  • 38. Genetics and molecular biology.
    Ochoa A; Zakin MM
    Curr Opin Lipidol; 1998 Aug; 9(4):367-9. PubMed ID: 9739493
    [No Abstract]   [Full Text] [Related]  

  • 39. Genetic regulation of apolipoproteins.
    Breslow JL
    Am Heart J; 1987 Feb; 113(2 Pt 2):422-7. PubMed ID: 2880491
    [No Abstract]   [Full Text] [Related]  

  • 40. Atherosclerosis: from genetic polymorphisms to system genetics.
    Cambien F; Tiret L
    Cardiovasc Toxicol; 2005; 5(2):143-52. PubMed ID: 16046790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.